TCL Archive In Brief: Progress Reported In NCI-FDA Fight Over New Drug Tests, Epidemiology Branch Reorganized December 12, 1975
TCL Archive In Brief: Registration Deadlines Coming Up For 13th Cancer Congress; Breast Cancer Meeting Postponed To ‘83 May 28, 1982
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation November 13, 1992
